Compumedics Ltd (CMP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Compumedics Ltd (CMP) has a cash flow conversion efficiency ratio of 0.129x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$2.81 Million ≈ $1.98 Million USD) by net assets (AU$21.82 Million ≈ $15.44 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Compumedics Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Compumedics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read CMP total debt and obligations for a breakdown of total debt and financial obligations.
Compumedics Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Compumedics Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mtag Group Berhad
KLSE:0213
|
0.115x |
|
AbL Diagnostics SA
PA:ABLD
|
0.069x |
|
Kaya Limited
NSE:KAYA
|
-0.131x |
|
WebCash Corporation
KQ:053580
|
0.047x |
|
Urban Jakarta Propertindo Tbk PT
JK:URBN
|
-0.009x |
|
R.P.P. Infra Projects Limited
NSE:RPPINFRA
|
0.013x |
|
Koss Corporation
NASDAQ:KOSS
|
-0.025x |
|
TechPrecision Corporation Common stock
NASDAQ:TPCS
|
-0.119x |
Annual Cash Flow Conversion Efficiency for Compumedics Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Compumedics Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Compumedics Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$21.82 Million ≈ $15.44 Million |
AU$681.00K ≈ $481.85K |
0.031x | -71.60% |
| 2024-06-30 | AU$18.21 Million ≈ $12.88 Million |
AU$2.00 Million ≈ $1.42 Million |
0.110x | +4001.92% |
| 2023-06-30 | AU$18.29 Million ≈ $12.94 Million |
AU$49.00K ≈ $34.67K |
0.003x | -98.08% |
| 2022-06-30 | AU$23.59 Million ≈ $16.69 Million |
AU$3.29 Million ≈ $2.33 Million |
0.139x | +133.15% |
| 2021-06-30 | AU$22.16 Million ≈ $15.68 Million |
AU$1.32 Million ≈ $936.81K |
0.060x | -75.80% |
| 2020-06-30 | AU$21.79 Million ≈ $15.42 Million |
AU$5.38 Million ≈ $3.81 Million |
0.247x | +31.37% |
| 2019-06-30 | AU$27.32 Million ≈ $19.33 Million |
AU$5.14 Million ≈ $3.63 Million |
0.188x | +678.97% |
| 2018-06-30 | AU$23.16 Million ≈ $16.39 Million |
AU$559.00K ≈ $395.53K |
0.024x | -43.99% |
| 2017-06-30 | AU$20.05 Million ≈ $14.19 Million |
AU$864.00K ≈ $611.34K |
0.043x | -71.82% |
| 2016-06-30 | AU$14.60 Million ≈ $10.33 Million |
AU$2.23 Million ≈ $1.58 Million |
0.153x | -21.75% |
| 2015-06-30 | AU$11.27 Million ≈ $7.97 Million |
AU$2.20 Million ≈ $1.56 Million |
0.195x | +161.00% |
| 2014-06-30 | AU$9.16 Million ≈ $6.48 Million |
AU$686.00K ≈ $485.39K |
0.075x | +52.92% |
| 2013-06-30 | AU$8.35 Million ≈ $5.91 Million |
AU$409.00K ≈ $289.39K |
0.049x | -67.21% |
| 2012-06-30 | AU$9.21 Million ≈ $6.52 Million |
AU$1.38 Million ≈ $973.61K |
0.149x | +824.18% |
| 2011-06-30 | AU$12.76 Million ≈ $9.02 Million |
AU$-263.00K ≈ $-186.09K |
-0.021x | -155.39% |
| 2010-06-30 | AU$12.20 Million ≈ $8.63 Million |
AU$454.00K ≈ $321.23K |
0.037x | -90.65% |
| 2009-06-30 | AU$11.48 Million ≈ $8.12 Million |
AU$4.57 Million ≈ $3.23 Million |
0.398x | +81.71% |
| 2008-06-30 | AU$8.51 Million ≈ $6.02 Million |
AU$1.86 Million ≈ $1.32 Million |
0.219x | +78.76% |
| 2007-06-30 | AU$6.91 Million ≈ $4.89 Million |
AU$847.00K ≈ $599.31K |
0.123x | +159.71% |
| 2006-06-30 | AU$6.72 Million ≈ $4.75 Million |
AU$-1.38 Million ≈ $-975.02K |
-0.205x | -423.10% |
| 2005-06-30 | AU$9.35 Million ≈ $6.61 Million |
AU$-366.59K ≈ $-259.39K |
-0.039x | -120.80% |
| 2004-06-30 | AU$13.95 Million ≈ $9.87 Million |
AU$2.63 Million ≈ $1.86 Million |
0.189x | -25.53% |
| 2003-06-30 | AU$11.68 Million ≈ $8.26 Million |
AU$2.96 Million ≈ $2.09 Million |
0.253x | +7762.90% |
| 2002-06-30 | AU$30.23 Million ≈ $21.39 Million |
AU$97.33K ≈ $68.87K |
0.003x | -88.40% |
| 2001-06-30 | AU$32.16 Million ≈ $22.76 Million |
AU$893.11K ≈ $631.93K |
0.028x | -- |
About Compumedics Ltd
Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST… Read more